Small red blood cells, normal hemoglobin: what a low MCV means and what is checked next

You open a routine blood count. Hemoglobin is inside the reference range, there is no anemia — and yet one line is flagged: MCV, low. Maybe also MCH. The report does not say what to do with it, and it is easy to decide that a normal hemoglobin settles the question.

It does not quite settle it. Small red cells with normal hemoglobin can point to one of two very different situations, and they are told apart by a test that was not on the form.

This material is for information only and does not replace a consultation with a doctor.

What does a low MCV actually measure?

MCV — mean corpuscular volume — is the average size of your red blood cells, in femtolitres. MCH is the average amount of hemoglobin per cell. When MCV is low, the cells are small; doctors call that microcytosis. When MCH is low, each cell carries less hemoglobin; that is hypochromia. The two often travel together.

The reference range is printed next to your number for a reason: it depends on age. A value is read against the range for your age, not against a number remembered from someone else's report.

How can hemoglobin be normal if the cells are small?

Because the total depends on two things: how big each cell is and how many cells there are. Two common situations produce small cells while the total still holds:

• Iron deficiency that has not yet become anemia. Iron stores fall before hemoglobin does: ferritin can be low while hemoglobin is still inside the reference range. Smaller cells can appear in that interval, but a normal MCV does not rule out low stores, and the studies cited here did not measure how often the cells shrink before the hemoglobin falls.

• A thalassemia trait. This is an inherited carrier state of a hemoglobin gene. In beta-thalassemia trait the body makes more red cells than usual, and they are small; hemoglobin is normal or only slightly low. That pattern is not iron deficiency. Iron does not correct the trait when iron stores are not low. If ferritin is also low, that is a separate finding, and iron status is still worth clarifying with a doctor.

These two call for opposite decisions, which is why the next step matters more than the flag itself.

Which test separates the two?

Ferritin — the blood marker of iron stores. In a systematic overview of 55 studies of people being investigated for iron-deficiency anemia, blood tests were compared with bone-marrow iron (the reference standard; studies had to include marrow histology for at least half of an identifiable patient group). Serum ferritin was by far the most powerful test, with an area under the ROC curve of 0.95. The same overview found that the test behaves differently in people with inflammatory, liver or neoplastic disease. What this does not say: those studies were of anemia, not of a normal hemoglobin.

What this does not say: a low ferritin confirms low iron stores, but it does not tell you why stores are low. That is a separate question.

Why is ferritin checked together with CRP?

Ferritin is also an acute-phase protein: it rises with infection and inflammation, regardless of iron stores. Infection and inflammation can raise ferritin even when iron stores are low, so an empty store can look full on that one result.

How big this effect is was measured in the BRINDA project, which pooled population surveys of preschool children (about 29,800) and non-pregnant women of reproductive age (about 25,700). Adjusting ferritin for inflammation by regression on CRP and AGP increased the estimated share of people with iron deficiency by a median of 25 percentage points in the children and 8 percentage points in the women. What this does not say: these are population estimates, and the authors write that how well such adjustment works for an individual patient in clinic still needs research.

That is why guidelines read ferritin alongside an inflammation marker from the same draw (CRP or AGP). The surveys do not show that repeating the test a set number of weeks later fixes the reading for one person.

Where is the ferritin cut-off?

There is more than one, and they answer different questions:

• WHO (2020). For apparently healthy people, ferritin below 12 µg/L in children under five and below 15 µg/L in children aged five and older and in adults indicates iron deficiency. Where there is infection or inflammation the thresholds in that table are higher: below 30 µg/L under five and below 70 µg/L from age five through adulthood. Pregnancy is a separate row: below 15 µg/L in the first trimester, and the table does not give an inflammation cutoff for pregnancy.

• American Gastroenterological Association (2020). In patients with anemia, the guideline recommends a ferritin cut-off of 45 ng/mL rather than 15 ng/mL to diagnose iron deficiency (strong recommendation). It was written for gastrointestinal evaluation of anemic adults. It is not a threshold for children, and it is not a threshold for people without anemia.

The practical point: which threshold applies depends on age, on whether there is anemia, and on whether there is inflammation. "Ferritin is in the lab's range" and "iron stores are adequate" are not always the same statement.

Can the blood count itself tell a trait from iron deficiency?

Partly. In 1973 Mentzer proposed dividing MCV by the red cell count: many small cells suggest a trait, fewer small cells suggest iron deficiency. More than 40 such indices have been proposed since.

A meta-analysis of 99 articles covering 12 indices (each studied at least five times), in people with microcytic anemia, found that none is 100% sensitive and specific. The best performer was the ratio of microcytic to hypochromic cells, and even it was not accurate enough for a definitive diagnosis. The indices performed better in adults than in children. What this does not say: those articles were about anemia, not about a low MCV with normal hemoglobin. What the authors conclude is narrow: an index helps decide who should get confirmatory testing; it does not replace that testing.

For beta-thalassemia trait, confirmation is a hemoglobin analysis that includes HbA2, measured by HPLC or electrophoresis and interpreted by a laboratory. Alpha-thalassemia trait is not confirmed by a raised HbA2. A normal hemoglobin does not by itself show that iron stores are normal, so iron status is read together with that analysis.

Does it matter if iron is low but hemoglobin is normal?

The trials here are small, and that should be said up front.

• In a randomized, placebo-controlled trial in four Baltimore high schools, 716 adolescent girls were screened and 81 with ferritin of 12 µg/L or less and normal hemoglobin were enrolled. After eight weeks, the iron group did better than placebo on a test of verbal learning and memory — one of four cognitive tests used. The trial was small and short.

• In a randomized trial in France, 198 menstruating women aged 18–53 with unexplained fatigue, ferritin below 50 µg/L and hemoglobin above 12 g/dL took oral iron or placebo for 12 weeks. Fatigue scores fell by 47.7% with iron and by 28.8% with placebo; quality of life, depression and anxiety did not differ.

• A meta-analysis of 32 studies (randomized and quasi-randomized trials) in 7,089 children aged 5–12 found better global cognitive scores and attention with iron supplementation. What it does not say: 31 of the 32 trials were done in low- or middle-income settings, the IQ gain was shown in anemic children, and the authors note that safety data were limited. How far this transfers to non-anemic children elsewhere is not established.

These trials do not add up to a general case for correcting iron deficiency before anemia. One is a small, short trial in non-anemic adolescent girls; one is a fatigue trial in menstruating women with ferritin below 50 µg/L, not a trial of heavy periods; the children's review is mostly from low- and middle-income settings, and the IQ result was in anemic children. None of them tested iron when ferritin was normal.

What does this number not mean?

• A low MCV is not a diagnosis. It is a pointer to two or three possible explanations.

• It is not a reason to start iron without a ferritin result. If the cause is a trait and ferritin is not low, iron does not correct the trait.

• In adults, iron deficiency anemia needs an explanation. For asymptomatic men and postmenopausal women with iron-deficiency anemia, the AGA guideline recommends bidirectional endoscopy (examination of the upper tract and the colon), not a blood count alone.

What to do with the number

If MCV is low and hemoglobin is normal, the next conversation with a doctor is usually about ferritin together with an inflammation marker (CRP or AGP) from the same blood draw. A result taken during an illness is harder to read; the surveys do not set a number of weeks to wait. If ferritin is low, the conversation with your doctor is about the cause and about correction. If ferritin is normal and the cells stay small on a repeat count, the doctor may order a hemoglobin analysis to look for a trait — which is worth knowing once, including for family planning.

Keep earlier blood counts: one value is a snapshot, and a series shows whether MCV has always been low or has been drifting down.

Sources

• Guyatt GH et al. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992. PMID 1487761

• Suchdev PS et al. Assessment of iron status in settings of inflammation: challenges and potential approaches (BRINDA). Am J Clin Nutr. 2017. PMID 29070567

• World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. 2020. PMID 33909381

• Ko CW et al. AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia. Gastroenterology. 2020. PMID 32810434

• Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973. PMID 4123424

• Hoffmann JJ et al. Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis. Clin Chem Lab Med. 2015. PMID 26536581

• Ryan K et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010. PMID 20067565

• Bruner AB et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996. PMID 8855856

• Vaucher P et al. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012. PMID 22777991

• Low M et al. Effects of daily iron supplementation in primary-school-aged children: systematic review and meta-analysis of randomized controlled trials. CMAJ. 2013. PMID 24130243